Fear of Cancer Recurrence after Curative Pancreatectomy: A Cross-sectional Study in Survivors of Pancreatic and Periampullary Tumors
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
BackgroundFear of disease recurrence is well documented among cancer survivors, but its significance among patients treated for solid pancreatic and periampullary neoplasms is unknown despite the known risk of recurrence associated with these tumors. We hypothesized that fear of cancer recurrence (FCR) represents a common source of psychosocial distress in this population and sought to characterize subgroups for whom FCR might represent a target for intervention to improve quality of life.MethodsWe conducted a cross-sectional study of FCR in patients who were disease-free after potentially curative pancreatectomy for ductal or periampullary adenocarcinoma or pancreatic neuroendocrine tumor. We assessed seven discrete dimensions of FCR using the Fear of Recurrence Inventory and evaluated quality of life and psychosocial distress using the Functional Assessment of Cancer Therapy-Hepatobiliary Questionnaire and the Hospital Anxiety and Depression Scale.ResultsOf 354 eligible patients, 240 (68 %) participated in the study a median of 48 months after potentially curative pancreatectomy. An FCR severity score indicative of frequent fearful thoughts, emotional disturbance and functional impairment was identified in 37, 28, and 35 % of patients with pancreatic adenocarcinoma, nonpancreatic periampullary adenocarcinoma, and pancreatic neuroendocrine tumor, respectively. Anxiety (P < 0.001) and low quality of life (P = 0.028) were independently associated with a clinically significant level of FCR, but histopathologic diagnosis and clinicopathologic markers of prognosis were not.ConclusionsFCR represents a significant concern for one-third of patients after curative surgery for a pancreatic or periampullary tumor, regardless of their actual likelihood of recurrence or disease-related death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Herrmann, C. (1997) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(96)00216-4 · Cited by 2,885
Simard, S., & Savard, J. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-008-0444-y · Cited by 608
Self-citationArmes, J., Crowe, M., Colbourne, L., Morgan, H., Murrells, T., Oakley, C., Palmer, N., Ream, E., Young, A., & Richardson, A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.5151 · Cited by 587 · cited 1×
“Substantial fear of recurrence remains long after the initial diagnosis of cancer, and ongoing management of FCR represents one of cancer survivors’ most important unmet needs.(5,6)”
Koch, L., Jansen, L., Brenner, H., & Arndt, V. (2013) · Psycho-Oncology · doi:10.1002/pon.3022 · Cited by 511 · cited 3×
“Similar findings have been reported among survivors of other cancers, and explain why management of FCR remains one of the most important unmet needs endorsed by patients who have survived with cancer for 5 years or longer.(6,23) To the extent that a short course of psychotherapy may effectively yield a long-term redu…”
Communicating prognosis in cancer care: a systematic review of the literature
Hagerty, R. G., Butow, P. N., Ellis, P. M., Dimitry, S., & Tattersall, M. H. N. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi211 · Cited by 504
Vickberg, S. M. J. (2003) · Annals of Behavioral Medicine · doi:10.1207/s15324796abm2501_03 · Cited by 468
Fear of cancer recurrence: a systematic literature review of self‐report measures
Thewes, B., Butow, P., Zachariae, R., Christensen, S., Simard, S., & Gotay, C. (2012) · Psycho-Oncology · doi:10.1002/pon.2070 · Cited by 262 · cited 2×
“have historically been used to measure FCR and because those instruments (other than the FCRI) have not been evaluated using external criteria such as a clinical interview.(14) With the FCRI we used, however, Simard et al.”
Self-citationFear of cancer recurrence: specific profiles and nature of intrusive thoughts
Simard, S., Savard, J., & Ivers, H. (2010) · Journal of Cancer Survivorship · doi:10.1007/s11764-010-0136-8 · Cited by 229 · cited 1×
“9 among 1,984 patients with breast, prostate, colorectal and lung cancer.(4) Together with the associations we have demonstrated between FCR, anxiety and QOL, these data clearly suggest the clinical importance of FCR after pancreatectomy.”
Self-citationPrimary Health and Supportive Care Needs of Long-Term Cancer Survivors: A Questionnaire Survey
Harrison, S. E., Watson, E. K., Ward, A. M., Khan, N. F., Turner, D., Adams, E., Forman, D., Roche, M. F., & Rose, P. W. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.5167 · Cited by 176
Herschbach, P., Berg, P., Waadt, S., Duran, G., Engst-Hastreiter, U., Henrich, G., Book, K., & Dinkel, A. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000254903 · Cited by 161 · cited 1×
“To the extent that a short course of psychotherapy may effectively yield a long-term reduction in FCR, these data support the screening of all patients for severe FCR early in the postoperative survivorship period—even patients believed to be at relatively low risk for recurrence.(27,28) The FCRI severity subscale pro…”
Research works printed but not linked: 12
- Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring? Cancer. 2005;104:2565–76. · DOI · Paper page
- Lee-Jones C, Humphris G, Dixon R, Hatcher MB. Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology. 1997;6:95–105. · doi:10.1002/(sici)1099-1611(199706)6:2<95::aid-pon250>3.0.co;2-b
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. · DOI · Paper page
- Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, et al. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol. 2009;16:836–47. · DOI · Paper page
- Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann Surg. 2006;244:10–5. · DOI · Paper page
- Ferrone CR, Tang LH, Tomlinson J, Gonen M, Hochwald SN, Brennan MF, et al. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? J Clin Oncol. 2007;25:5609–15. · DOI
- Hwang RF, Wang H, Lara A, Gomez H, Chang T, Sieffert N, et al. Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. Ann Surg Oncol. 2008;15:1356–66. · DOI
- Tzeng CW, Fleming JB, Lee JE, Wang X, Pisters PW, Vauthey JN, et al. Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. HPB (Oxford). 2012;14:365–72. · DOI
- Simard S, Savard J. A confirmatory factor analysis of the fear of cancer recurrence inventory (FCRI)—French version. Psychooncology. 2010;19:(suppl 2):S16. · DOI
- Heffernan N, Cella D, Webster K, Odom L, Martone M, Passik S, et al. Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire. J Clin Oncol. 2002;20:2229–39. · DOI · Paper page
- Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70. · DOI · Paper page
- Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52:69–77. · DOI · Paper page
Cited by
Luigjes‐Huizer, Y. L., Tauber, N. M., Humphris, G., Kasparian, N. A., Lam, W. W. T., Lebel, S., Simard, S., Smith, A. B., Zachariae, R., Afiyanti, Y., et al. (2022) · Psycho-Oncology · doi:10.1002/pon.5921 · Cited by 332
Self-citationSimonelli, L. E., Siegel, S. D., & Duffy, N. M. (2017) · Psycho-Oncology · doi:10.1002/pon.4168 · Cited by 292
Quality of Life in Patients With Pancreatic Cancer and Their Caregivers: A Systematic Review
Bauer, M. R., Bright, E. E., MacDonald, J. J., Cleary, E. H., Hines, O. J., & Stanton, A. L. (2018) · Pancreas · doi:10.1097/mpa.0000000000001025 · Cited by 107
Spotlight on the Fear of Cancer Recurrence Inventory (FCRI)
Smith, A. B., Costa, D., Galica, J., Lebel, S., Tauber, N., van Helmondt, S. J., & Zachariae, R. (2020) · Psychology Research and Behavior Management · doi:10.2147/prbm.s231577 · Cited by 98
Fear of cancer recurrence and its predictors among cervical cancer survivors
Hanprasertpong, J., Geater, A., Jiamset, I., Padungkul, L., Hirunkajonpan, P., & Songhong, N. (2017) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2017.28.e72 · Cited by 86
“There is evidence that higher levels of FCR are associated with poorer QOL among several types of cancer survivors such as breast, colorectal, lung, pancreatic and periampullary, urogynecologic, and testicular cancers [10,14,27,30,31].”
BackgroundResultInfluential
Metadata
- Authors
- Petzel, M. Q. B., Parker, N. H., Valentine, A. D., Simard, S., Nogueras-Gonzalez, G. M., Lee, J. E., Pisters, P. W. T., Vauthey, J.-N., Fleming, J. B., & Katz, M. H. G.
- Venue
- Annals of Surgical Oncology
- Published
- 2012-08-09
- Volume
- 19
- Issue
- 13
- Pages
- 4078-4084
- ISSN
- 1068-9265 (ISSN-L)
- 1534-4681
- OpenAlex
- W2045725702
- Cited by
- 63
- References
- 14
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fear of Cancer Recurrence after Curative Pancreatectomy: A Cross-sectional Study in Survivors of Pancreatic and Periampullary Tumors. https://app.cochat.ai/papers/10.1245/s10434-012-2566-1
- The paper
- Petzel, M. Q. B., Parker, N. H., Valentine, A. D., Simard, S., Nogueras-Gonzalez, G. M., Lee, J. E., Pisters, P. W. T., Vauthey, J.-N., Fleming, J. B., & Katz, M. H. G. (2012). Fear of Cancer Recurrence after Curative Pancreatectomy: A Cross-sectional Study in Survivors of Pancreatic and Periampullary Tumors. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-012-2566-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.